Introduction: Chronic kidney disease (CKD) is a condition characterized by kidney damage or reduced function lasting at least 3 months. Hemodialysis (HD) is a key treatment for CKD, replacing kidney function in fluid and acid–base electrolyte balance, metabolic waste removal, and blood pressure management. Intradialytic weight gain (IDWG) is a common HD complication, with patients with limited systolic blood pressure having the highest risk of intradialytic hypotension (IDH)-related death. This research examined IDWG patterns in patients on regular HD. Methods: A prospective, observational study of 40 end-stage renal disease patients on regular HD twice a week at Dr. Soetomo Hospital was conducted for 3 months. Every patient received HD for at least 3 months. Data from purposive sampling. Statisticians used IBM SPSS ® Statistics 25. Results: A total of 20 out of 40 IDWG subjects experienced IDH. In the IDH group, the percentage of women was 11 (55%) people, the mean age of the research subjects was 49.9 ± 9.70 years, the mean duration on HD of the research subjects was 70.5 ± 43.78 months, and the mean IDWG percentage (IDWG%) of the research subjects was 5.36 ± 1.1. By statistical analysis, a correlation value of P = 0.008 was obtained. Conclusion: There was a correlation between IDWG% and the incidence of IDH, with or without confounding factors such as gender, age, and duration of HD. The higher the percentage value of IDWG, the higher the IDH incidence rate.
Metabolic dysfunction-associated steatotic liver disease (MASLD) involves early disturbances such as excessive lipid accumulation, sterile inflammation, and hepatocellular stress. The results of recent studies have highlighted extracellular ATP and its metabolite adenosine (Ado) as damage-associated molecular patterns (DAMPs) that drive inflammation, endoplasmic reticulum (ER) stress, and steatosis, contributing to MASLD progression. Although vitamin E is clinically used for its antioxidant and anti-inflammatory properties, it remains unclear whether its therapeutic effects involve modulation of DAMP-associated signaling. To address this gap, we used transgenic zebrafish expressing a liver-specific G-protein-coupled receptor activation-based adenosine sensor (GRABAdo). We found that a high-cholesterol diet markedly increased hepatic extracellular Ado levels, combined with inflammatory and ER stress-associated gene expression. Vitamin E significantly reduced extracellular Ado levels and hepatic lipid accumulation. Based on RNA sequencing results, vitamin E restored the expression of genes encoding calcium-handling proteins, including atp2a1 and atp1b1b. These genes encode components of the sarco/ER Ca2+-ATPase (SERCA) machinery, which is essential for maintaining ER Ca2+ homeostasis and preventing stress-induced hepatic injury. CDN1163-mediated SERCA activation phenocopied the protective effect of vitamin E, supporting a Ca2+-dependent mechanism. Together, these findings highlight extracellular Ado signaling and impaired SERCA-mediated Ca2+ regulation as early drivers of MASLD and demonstrate that vitamin E ameliorates steatosis by targeting both pathways.